Reaction

Fungal Skin Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,952 reports · 140 co-occurring drugs

As of the last recalculation, Fungal Skin Infection appears in 3,952 FAERS reports alongside 140 co-occurring drug terms. The strongest observed disproportionality signal is TERBINAFINE HYDROCHLORIDE (PRR 23.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Terbinafine Hydrochloride	39	23.3	23.4
Amphotericin B	47	20.0	20.1
Valganciclovir Hydrochloride Powder,	41	17.9	17.9
Basiliximab	38	17.2	17.2
Voriconazole Injection	64	15.8	15.8
Tacrolimus Ointment 0.1%	299	13.6	13.6
Tacrolimus Extended-Release Capsules	299	13.6	13.6
Ketoconazole Foam	36	12.9	13.0
Ketoconazole	42	12.9	12.9
Ketoconazole Cream, 2%	36	12.9	12.9
Valganciclovir	44	12.4	12.4
Valganciclovir Hydrochloride	44	12.4	12.4
Nystatin Cream	60	12.2	12.2
Nystatin	62	12.1	12.1
Alemtuzumab	44	12.1	12.1
Nystatin Ointment	59	12.0	12.0
Voriconazole	68	12.0	12.0
Tacrolimus	324	11.8	11.8
Posaconazole Delayed-Release	24	11.6	11.6
Itraconazole	25	11.3	11.4
Micafungin Sodium	18	11.2	11.2
Mycophenolate Mofetil	271	11.2	11.2
Mycophenolate Mofetil Hydrochloride	271	11.2	11.2
Clotrimazole	23	9.9	9.9
Baricitinib	18	9.9	9.9
Drs. Clotrimazole	20	9.2	9.2
Family Wellness Clotrimazole	20	9.2	9.2
Clotrimazole Topical	20	9.2	9.2
Ampicillin	13	8.3	8.3
Ampicillin Sodium	13	8.3	8.3
Fluconazole	106	8.2	8.2
Posaconazole	24	7.8	7.8
Mycophenilic Acid	28	7.2	7.2
Canagliflozin	40	7.1	7.1
Anakinra	22	7.0	7.0
Mometasone	24	6.9	6.9
Diphenhydramine Hydrochloride Capsule, Liquid Filled	27	6.7	6.7
Human Immunoglobulin G	25	6.4	6.4
Methylprednisolone	154	6.1	6.1
Miconazole Nitrate	10	6.0	6.1
Bimekizumab	24	6.0	6.0
Desloratadine	11	5.4	5.4
Prednisolone	175	5.3	5.3
Prednisolone Oral	175	5.3	5.3
Prednisolone Oral Solution	175	5.3	5.3
Cyclobenzaprine Hydrochloride	9	5.3	5.3
Anti-Thymocyte Globulin (Rabbit)	8	5.2	5.2
Botulinum Toxin Type A	12	5.1	5.1
Infliximab-Dyyb	28	5.1	5.1
Fludarabine Phosphate	37	5.0	5.0
Mycophenolic Acid	30	5.0	5.0
Mupirocin	12	4.7	4.7
Mupirocin Calcium	12	4.6	4.6
Zinc	21	4.5	4.5
Azathioprine	74	4.5	4.5
Zinc Chloride	21	4.5	4.5
Butalbital, Acetaminophen, And Caffeine	9	4.5	4.5
Ixekizumab	30	4.3	4.3
Zinc Gluconate	21	4.2	4.3
Biotin	25	4.2	4.2
Oxybutynin Chloride	7	4.2	4.2
Tizanidine	19	4.2	4.2
Rizatriptan Benzoate	8	4.1	4.2
Clindamycin Phosphate	26	4.1	4.1
Clobetasol Propionate	8	4.1	4.1
Azacitidine For	14	4.1	4.1
Gentamicin	10	4.0	4.0
Hydroxyzine Hydrochloride	10	4.0	4.0
Hydroxyzine Hydrochloride Oral	10	4.0	4.0
Gentamicin Sulfate	12	4.0	4.0
Daptomycin	7	4.0	4.0
Iron	50	4.0	4.0
Adrenalinum	31	4.0	4.0
Zidovudine	10	3.9	3.9
Risankizumab-Rzaa	60	3.9	3.9
Pegaspargase	9	3.9	3.9
Diphenhydramine	46	3.9	3.9
Clobetasol Propionate Ointment Usp, 0.05%	7	3.6	3.6
Tocilizumab	76	3.6	3.6
Valacyclovir	28	3.6	3.6
Ravulizumab	9	3.5	3.5
Lovastatin	17	3.5	3.5
Certolizumab Pegol	75	3.4	3.4
Tofacitinib	114	3.3	3.3
Empagliflozin	41	3.2	3.2
Fexofenadine	10	3.2	3.2
Upadacitinib	49	3.2	3.2
Ocrelizumab	37	3.2	3.2
Triamcinolone Acetonide Ointment Usp, 0.05%	14	3.2	3.2
Adalimumab	395	3.2	3.2
Meropenem	19	3.1	3.1
Fexofenadine Hydrochloride	12	2.9	2.9
Cytarabine	33	2.9	2.9
Ibrutinib	42	2.8	2.8
Axitinib	10	2.7	2.7
Lanreotide Acetate	4	2.7	2.7
Fingolimod Hcl	42	2.6	2.6
Ofatumumab	16	2.5	2.5
Azacitidine	14	2.5	2.5
Dupilumab	220	2.5	2.5
Linezolid	14	2.5	2.5
Ruxolitinib	33	2.4	2.4
Siponimod	4	2.4	2.4
Guselkumab	16	2.4	2.4
Secukinumab	71	2.3	2.3
Golimumab	36	2.2	2.2
Macitentan	29	2.2	2.2
Cabozantinib	20	2.2	2.2
Erlotinib	4	2.2	2.2
Etanercept	238	2.2	2.2
Venetoclax	25	2.1	2.1
Nemolizumab-Ilto	5	2.1	2.1
Lapatinib	6	2.0	2.0
Dasatinib	14	2.0	2.0
Vibegron	3	2.0	2.0
Methadone Hydrochloride	4	1.9	1.9
Sarilumab	9	1.8	1.8
Cariprazine	3	1.7	1.7
Ribavirin	20	1.6	1.6
Dalfampridine	22	1.6	1.6
Eltrombopag Olamine	7	1.6	1.6
Peginterferon Alfa-2A	16	1.6	1.6
Teriflunomide	13	1.5	1.5
Budesonide, Glycopyrrolate, And Formoterol Fumarate	3	1.5	1.5
Paricalcitol	4	1.5	1.5
Palbociclib	25	1.4	1.4
Diroximel Fumarate	3	1.3	1.3
Natalizumab	44	1.3	1.3
Alirocumab	6	1.3	1.3
Relugolix	5	1.1	1.1
Vigabatrin	3	1.1	1.1
Lenalidomide	85	1.1	1.1
Palivizumab	3	1.0	1.0
Osimertinib	6	1.0	1.0
Minoxidil Foam 5% (Womens)	5	0.8	0.8
Apremilast	22	0.8	0.8
Copper	6	0.7	0.7
Minoxidil	6	0.7	0.7
Salicylic Acid	6	0.6	0.6
Adapalene	5	0.1	0.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.